Passkey Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Kendall Sq Bldg 200 Ste 1, Cambridge, ...Website
www.passkeytx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Passkey Therapeutics
Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics (SMThs), designed to address complex diseases by targeting rare combinations of proteins that work together. Using its proprietary Locksmith platform, the company is advancing programs across multiple therapeutic areas to create new options for patients with common, hard-to-treat conditions.Explore more
Passkey Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Passkey Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Passkey Therapeutics
Website visits: Recent activity has been detected on your website
Check out if Passkey Therapeutics is spiking on competitors!
Click to see if Passkey Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Passkey Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Passkey Therapeutics has new funding data
Passkey Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Passkey Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Passkey Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Passkey Therapeutics
Compare insights from companies similar to Passkey Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$9.1M
11-50
Private
$220M
2020
Mehrdad HamadaniChief Technology Officer & Executive VP, Engineering, Artificial Intelligence & Operations
Company Profile Activity
Activity Insights
Passkey Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Passkey Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Passkey Therapeutics.
Passkey Therapeutics financials insights
Gather financial insights about Passkey Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Angel/Seed
$20M
Passkey Therapeutics Tech Stack
A closer look at the technologies used by Passkey Therapeutics
Passkey Therapeutics News & Media
Passkey Therapeutics Raises $20 Million to Advance a New Class of Multifunctional Therapeutics with Proprietary Platform Targeting Rare Combinations of Proteins
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Passkey Therapeutics Raises $20 Million to Advance a New Class of Multifunctional Therapeutics with Proprietary Platform
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Passkey Therapeutics
Sign Up For FreeTo access detailed company insights
Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics (SMThs), designed to address complex diseases by targeting rare combinations of proteins that work together. Using its proprietary Locksmith platform, the company is advancing programs across multiple therapeutic areas to create new options for pat... Read More
